bioAffinity Technologies, Inc. (BIAF) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | Gross Profit |
| Revenue | 5.90M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $5.90M | (m) | (m) |
| 2026-03-31 | (m) | $5.66M | (m) | (m) |
| 2025-12-31 | (m) | $6.16M | (m) | (m) |
| 2025-09-30 | (m) | $6.78M | (m) | (m) |
| 2025-06-30 | (m) | $7.68M | (m) | (m) |
| 2025-03-31 | (m) | $8.81M | (m) | (m) |
| 2024-12-31 | (m) | $9.36M | (m) | (m) |
| 2024-09-30 | (m) | $9.37M | (m) | (m) |
| 2024-06-30 | (m) | $7.32M | (m) | (m) |
| 2024-03-31 | (m) | $4.94M | (m) | (m) |
| 2023-12-31 | (m) | $2.53M | (m) | (m) |
| 2023-09-30 | $245.29K | $321.49K | (m) | 76.30% |
| 2023-06-30 | $22.51K | $24.16K | (m) | 93.20% |
| 2023-03-31 | (m) | (m) | (m) | (m) |
| 2022-12-31 | $4.34K | $4.80K | (m) | 90.28% |
| 2022-09-30 | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |